Sean Maduck - Mar 1, 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role: Officer
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck
Stock symbol: CORT
Transactions as of: Mar 1, 2023
Transactions value $: $28,996
Form type: 4
Date filed: 3/3/2023, 05:54 PM
Previous filing: Dec 5, 2022
Next filing: Jun 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CORT	Common Stock	Award	$29K	+1.46K	+2.59%	$19.86	57.9K	Mar 1, 2023	Direct	F1, F2, F3
transaction	CORT	Common Stock	Award	$0	+1.46K	+2.52%	$0.00	59.4K	Mar 1, 2023	Direct	F3, F4
holding	CORT	Common Stock						10K	Mar 1, 2023	See Footnote	F5
holding	CORT	Common Stock						10K	Mar 1, 2023	See Footnote	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2023.
F2	In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
F3	Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F4	Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
F5	Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F6	Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.

Remarks:

President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.